Exchange: NASDAQ·Updated 07:30 PM EST
GPCR logo

GPCR Structure Therapeutics Inc - ADR

$16.69
$0.99
(5.78%)
Today
Closed $16.13
$0.56
(3.47%)
After Hours
EarningsFeb 25
Mkt Cap$1.15B
Vol786,235.00

About GPCR

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
57

Bullish Sentiment

How do you feel about GPCR?

murphylaw
$GPCR $NVO GPCR shares will only go up from here. Wegovy pill sales are growing and will keep growing. There is a big market for oral tablets. This is not a 20 dollar stock. Crazy fire sale at the moment. Smart investors will scoop it all up by end of 2026.
5
IM11
$GPCR I get that GPCR is stuck in Ph3 testing for 1.5 years, but if someone wants to buy them and not lose time getting to market, they are going to have to do it this time next year, 6 to 12 months ahead of Ph3 readout. Either way, how does a stock that rose to $94 on positive phase 2 data and backs it up with positive Extended trials replicating Ph3 and positive SAD data on a 2nd Amylin drug, fall from $94 to $16 with NO BAD DATA. The level of market manipulation across the biotech obesity sector right now is CRAZY!!!! I can't understand how this didn't get heavy buying pressure anywhere below $30.
3
Theflash88
$GPCR $VKTX So are all those big pharma companies out there let LLY and NOVO reap all the rewards from GLP-1’s?? I highly doubt it.. Something is about to give.
4
chartistmind
$GPCR Jabronis, do you need me to come back and put in the rock bottom on the candyass bears? $SPY
3
murphylaw
$GPCR load the boat for next week. Hopefully some stellar data. Need Merck buyout ASAP. Not sure what Merck is waiting for.
3
parrotineum
$GPCR The fall from $95 to under $19 in less than year with no fundamental change will be studied for years
3
murphylaw
$GPCR vktx rumors are always good. Obesity conference next week. Hopefully a big surprise next week. Last december and january were unbelievable. Fingers crossed!!
2
IM11
$GPCR in today's Lilly Quarterly Report, look at how many trials and extensions that Lilly is working on for Foundayo. Weight-Loss, Diabetes, Sleep Apnea, Pain Management, etc, etc. They know that Foundayo is the future and the first / biggest competitor to Foundayo will be Aleniglipron. Current share price is depressing, but this one is going to fly... In UK, Foundayo is priced around $150 a month with Tirz above $300 a month. When Lilly starts dropping the price in the US and Foundayo gets approved for diabetes, it will start to eat away at SQ market share, IMO. The only reason they haven't dropped the US price of Foundayo is the SQ market share they would be eating away at is their own Zepbound / Mounjaro, so they have no need to cut their own profit margins at the moment.
2
explover
$GPCR should work in T2D Will it be better than orforglipron? We shall see. Very attractive trading almost at cash.
1
parrotineum
$GPCR Not my favorite in the space but at this price it’s a good deal. Drug is not as good as what Viking has, but they have 1.3 Billion in cash and burn rate was 144 million on quarter. Looks like easily will cover their phase 3 trials.
1
POWELL_
$GPCR AGLENIPRION small molecule we loce small molecules folks less side effects and more effective than what the big wigs at eli lilly are offering
1
GainIntoxication
$GPCR Starting to look more interesting at this price level and lower, for obesity stock base covering. Not superior to VK2735 but may have a decent place at the trough in '29 or a take-out while you're in the drive-thru
IM11
$GPCR No quarterly update this morning? Should be due today, so suspect we are getting a quarterly update after hours today or else they are filing for an extension beyond the 40 days?
wall_street13
$GPCR 1.5B market cap with 1.3B in cash. I think that shows what people think of their drug and their future. basically, its worthless.

Advertisement|Remove ads.